ADMA Biologics, Inc.

NasdaqGM:ADMA Rapporto sulle azioni

Cap. di mercato: US$4.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

ADMA Biologics Crescita futura

Future criteri di controllo 4/6

Si prevede che ADMA Biologics aumenterà gli utili e i ricavi rispettivamente del 26% e 14.8% all'anno, mentre si prevede che l'EPS crescerà del 25.2% all'anno.

Informazioni chiave

26.0%

Tasso di crescita degli utili

25.2%

Tasso di crescita dell'EPS

Biotechs crescita degli utili30.3%
Tasso di crescita dei ricavi14.8%
Rendimento futuro del capitale proprion/a
Copertura analitica

Low

Ultimo aggiornamento12 Aug 2024

Aggiornamenti recenti sulla crescita futura

ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

May 13
ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

Recent updates

ADMA Biologics' (NASDAQ:ADMA) Strong Earnings Are Of Good Quality

Aug 16
ADMA Biologics' (NASDAQ:ADMA) Strong Earnings Are Of Good Quality

ADMA Biologics: A Compelling GARP Stock For Biotech Investors

Jul 27

ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Jul 24
ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?

Jul 17
Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?

Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

May 30
Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?

ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

May 13
ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next

Giving ADMA Biologics A Well-Deserved 'Booyah'

May 12

ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

May 08
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares

Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Apr 04
Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?

Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)

Apr 03

ADMA Biologics: On A Roll Entering 2024

Jan 19

Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

Jan 09
Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?

ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

Jan 09
ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Oct 25
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

Jun 10
We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt

The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

May 12
The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet

ADMA Biologics: Strong Growth Is Clearing The Path To Profitability

Aug 21

ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M

Aug 10

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Jun 01
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: A Path To Profits Looks Clear

May 12

ADMA: Pertinent Updates

Apr 18

ADMA Biologics' 2021 Numbers Showed Continued Strong Execution

Mar 29

ADMA Biologics: 2021 Was Tough

Jan 18

ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

Dec 02
ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt

ADMA Biologics: Turning A Corner

Nov 20

ADMA: Insiders Showing Their Cards

Nov 02

ADMA Biologics: Recent Significant Developments And Their Implications For The Stock

Aug 22

Previsioni di crescita degli utili e dei ricavi

NasdaqGM:ADMA - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20265291741751893
12/31/20254581571191534
12/31/2024406115581044
6/30/2024330356673N/A
3/31/2024283-41621N/A
12/31/2023258-2849N/A
9/30/2023234-23-23-16N/A
6/30/2023208-40-51-41N/A
3/31/2023182-48-61-48N/A
12/31/2022154-66-73-60N/A
9/30/2022130-70-99-86N/A
6/30/2022110-73-99-86N/A
3/31/202294-78-119-105N/A
12/31/202181-72-126-112N/A
9/30/202169-74-125-111N/A
6/30/202158-74-135-122N/A
3/31/202148-75-124-111N/A
12/31/202042-76-115-102N/A
9/30/202040-67-100-89N/A
6/30/202037-61-99-89N/A
3/31/202036-54-92-87N/A
12/31/201929-48-80-76N/A
9/30/201921-56-78-75N/A
6/30/201918-59-66-64N/A
3/31/201916-61-62-61N/A
12/31/201817-66-65-63N/A
9/30/201818-61-61-57N/A
6/30/201818-61-58-54N/A
3/31/201817-55N/A-48N/A
12/31/201716-44N/A-37N/A
9/30/201714-35N/A-28N/A
6/30/201712-24N/A-22N/A
3/31/201711-21N/A-18N/A
12/31/201611-20N/A-18N/A
9/30/201610-20N/A-19N/A
6/30/20169-20N/A-17N/A
3/31/20168-19N/A-16N/A
12/31/20157-18N/A-15N/A
9/30/20156-17N/A-14N/A
6/30/20156-15N/A-14N/A
3/31/20156-15N/A-14N/A
12/31/20146-17N/A-15N/A
9/30/20145-18N/A-15N/A
6/30/20145-17N/A-15N/A
3/31/20144-18N/A-13N/A
12/31/20133-16N/A-11N/A
9/30/20133-13N/A-10N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di ADMA ( 26% all'anno) è superiore al tasso di risparmio ( 2.5% ).

Guadagni vs Mercato: Si prevede che gli utili di ADMA ( 26% all'anno) cresceranno più rapidamente del mercato US ( 15.1% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di ADMA cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di ADMA ( 14.8% all'anno) crescerà più rapidamente del mercato US ( 8.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di ADMA ( 14.8% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di ADMA è previsto essere elevato tra 3 anni

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y